Navigation Links
Michael V. Novinski, Emisphere President/CEO Featured in the Wall Street Transcript
Date:5/16/2008

he company's current partnerships, highlighted by "two very exciting products with Novartis that are already well into Phase III [development]." Through this program, "by the middle of this year, more than 5,000 patients will be taking Emisphere's eligen(R) technology with Salmon Calcitonin for the treatment of osteoarthritis and osteoporosis," explained Mr. Novinski. "That's very exciting."

The entire Wall Street Transcript interview can be viewed at Emisphere's Website, http://www.emisphere.com.

ABOUT EMISPHERE TECHNOLOGIES, INC.

Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its eligen(R) Technology. Some of these molecules or compounds can only be given by injection; when combined with our technology; convenient oral versions may be safe, effective and provide significant advantages. The benefits of other compounds are limited due to poor bioavailability, slow on-set of action or variable absorption. In those cases, use of Emisphere's technology can improve the therapeutic effectiveness of the compounds. The eligen(R) technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, per rectum, pulmonary, intra-vaginal or transdermal. The web site is: http://www.emisphere.com.

Safe Harbor Statement Regarding Forward-Looking Statements

The statements in this release and oral statements made by representatives of Emisphere relating to matters that are not historical facts (including without limitation those regarding potential third party collaborations, future performance or financial results, the timing or potential outcomes of research collaborations or clinical trials, any market that might develop for any of Emisphere's product candidates and the sufficiency
'/>"/>

SOURCE Emisphere Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
2. Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
3. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
4. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
5. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
6. Pharmasset Appoints Michael Rogers as Chief Development Officer
7. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
8. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
9. Genstar Names Michael Hurt to Its Strategic Advisory Board
10. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
11. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 ... ) has announced the addition of the ... Opportunities, 2018" report to their offering. ... Lack of data protection and old ... PIN codes have driven the growth of ...
(Date:6/19/2013)...   NineSigma , Inc., of Cleveland ... launch, NineSights.com is now the innovation engine ... worldwide community of innovators. From technology developers, ... NineSights stands out for its large community of innovators ... disciplines, all vetted by NineSigma. The community is free ...
(Date:6/19/2013)... 2013 BioConvergence team members Curtis ... at 2013’s BioLogistics Summit in San Francisco earlier ... Cold Chain IQ and IQPC, addressed the increasingly ... in part, attributed to current trends of globalization, ... these trends is an increase in movement, which ...
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Adding ... Pipette.com is now stocked with Simport’s Dropette® and ... aimed at the customer doing basic biology, chemistry and ... and serology). , For over 35 years, Simport has ... plastic labware - products like the Simport Dropette®. Simport’s ...
Breaking Biology Technology:Global Biometric Systems Market Forecast Report - Opportunities to 2018 2Global Biometric Systems Market Forecast Report - Opportunities to 2018 3NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2
... p.m. (Pacific Time); ... http://www.adventrx.com , SAN DIEGO, March 13 ADVENTRX ... on in-licensing,developing and commercializing proprietary product candidates primarily for,the ... for the fourth quarter and year ended December 31, ...
... Brussels: THR), a biotechnology company focused on vascular,diseases, ... results for,the twelve month period ending 31 December ... to invest in its development,pipeline and has continued ... Highlights, - Successful placing of a total ...
... CITY, Mo., March 13 Proteon,Therapeutics, Inc. ( ... been issued by the European Patent Office. The ... of proteins known as elastases for,dilating arteries and ... related,United States patents in June and December of ...
Cached Biology Technology:ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 2ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 3ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 4ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 5ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 6ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results 7ThromboGenics Announces 2007 Full Year Results 2ThromboGenics Announces 2007 Full Year Results 3ThromboGenics Announces 2007 Full Year Results 4Proteon Therapeutics Receives European Patent Covering New Method of Dilating Arteries and Veins 2
(Date:6/19/2013)... new variety of canary seeds bred specifically for human ... ideal for people with celiac disease (CD), scientists have ... of Agricultural and Food Chemistry . , Joyce ... 3 million people in the United States alone have ... wheat, barley, rye and other grains that contain gluten-related ...
(Date:6/19/2013)... to contribute to a very large and potentially record-setting ... University of Michigan ecologist and colleagues who released their ... Bay. , The Gulf forecast, one of two announced ... an oxygen-depleted, or hypoxic, region of between 7,286 and ... 10 largest on record. , The low end of ...
(Date:6/18/2013)... Faculty of Medicine have discovered a mechanism that is ... a component of blood typically associated with clotting, were ... detection, seal it off from the rest of the ... Immunology this week, provide the science community with ... has known that platelets do participate in immunity, but ...
Breaking Biology News(10 mins):U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 3U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 4Immunity mechanism discovered 2
... 1, 2007A new Joslin-led study has shown that leptin, ... energy metabolism, plays a major role in islet cell ... new avenues for studying leptin and its role in ... for diabetes. This study appears in the October ...
... Engineers at Washington University in St. Louis are finding ... the heart during embryonic development. Larry A.Taber, ... Engineering, and Phillip Bayly, Ph.D., Hughes Professor of Mechanical ... in the folding of the brains surface, or cortex, ...
... , The New York Academy of Sciences, 7 World ... NY 10007 The Malaria Research Institute at the ... New York Academy of Sciences present Progress Against Malaria: ... the latest research developments in the fight to combat ...
Cached Biology News:Joslin researchers uncover potential role of leptin in diabetes 2Engineers study brain folding in higher mammals 2Engineers study brain folding in higher mammals 3Progress Against Malaria: Developments on the Horizon 2
PC based system for superior chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Request Info...
... Well Plate Sterile with ... range of 384-well plates ... screening and research. These ... and are suitable for ...
HLA-DRbeta (DA2)...
Biology Products: